Anticoagulation Prior to COVID-19 Infection Has No Impact on 6 Months Mortality: A Propensity Score–Matched Cohort Study

The coronavirus disease 2019 (COVID-19) shows high incidence of thromboembolic events in humans. In the present study, we aimed to evaluate if anticoagulation prior to COVID-19 infection may impact clinical profile, as well as mortality rate among patients hospitalized with COVID-19. The study was b...

Descripción completa

Detalles Bibliográficos
Autores principales: Protasiewicz, Marcin, Reszka, Konrad, Kosowski, Wojciech, Adamik, Barbara, Bombala, Wojciech, Doroszko, Adrian, Gajecki, Damian, Gawryś, Jakub, Guziński, Maciej, Jedrzejczyk, Maria, Kaliszewski, Krzysztof, Kilis-Pstrusinska, Katarzyna, Konopska, Bogusława, Kopec, Agnieszka, Kujawa, Krzysztof, Langner, Anna, Larysz, Anna, Lis, Weronika, Pawlik-Sobecka, Lilla, Gorka-Dynysiewicz, Joanna, Rosiek-Biegus, Marta, Matera-Witkiewicz, Agnieszka, Matys, Tomasz, Pomorski, Michał, Sokolski, Mateusz, Sokołowski, Janusz, Tomasiewicz-Zapolska, Anna, Madziarska, Katarzyna, Jankowska, Ewa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781160/
https://www.ncbi.nlm.nih.gov/pubmed/35054046
http://dx.doi.org/10.3390/jcm11020352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781160/
https://www.ncbi.nlm.nih.gov/pubmed/35054046
http://dx.doi.org/10.3390/jcm11020352

Ejemplares similares